Response to COVID-19 Vaccines in People with Chronic Conditions Trial Objective Researchers at National Jewish Health are working to understand the antibody response to COVID-19 vaccines in people with chronic diseases. Researchers are focused on the short-term and long-term antibody response by people with chronic respiratory diseases, as well as other chronic diseases. Enrollment Active Clinical Trials Closed to Recruitment Who Can Participate Individuals 18 and older who have received or will be receiving the COVID-19 vaccine. Age: 18+ Gender: Any Gender Estimated Time Commitment Up to 10 visits over the course of about 2 years × Payments are intended to compensate the participant for their time and effort during the study. Payments are typically given to the participant at the end of each completed study visit. Reimbursements are intended to compensate the participant for travel-related expenses. They must be approved by the study staff and require you to turn in receipts. Travel reimbursement will vary from study to study. Payment & Reimbursement Payment: Provided Travel Reimbursement: Not Available Trial Contact For more information, contact: Juno Pak 303.398.1132 Trial Location National Jewish Main Campus, Denver, CO Trial Sponsors Investigator Funded Principal Investigators Anthony Gerber, MD, PhD + × Anthony Gerber, MD, PhD Professor Department of Medicine Division of Pulmonary, Critical Care & Sleep Medicine Grant Program Director for the Office of Research Innovation Department of Immunology and Genomic Medicine View Full Profile Patient Rating 4.9 out of 5 stars Make an Appoinment Barry Make, MD + × Barry Make, MD Professor Department of Medicine Division of Pulmonary, Critical Care & Sleep Medicine View Full Profile Make an Appoinment Michael Wechsler, MD, MMSc + × Michael Wechsler, MD, MMSc Director, The Cohen Family Asthma Institute Professor Department of Medicine Division of Pulmonary, Critical Care & Sleep Medicine View Full Profile Patient Rating 4.8 out of 5 stars Make an Appoinment
Trial Objective Researchers at National Jewish Health are working to understand the antibody response to COVID-19 vaccines in people with chronic diseases. Researchers are focused on the short-term and long-term antibody response by people with chronic respiratory diseases, as well as other chronic diseases.